⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
RANI News
Rani Therapeutics Holdings, Inc. Class A Common Stock
Form 8-K
sec.gov
RANI
Rani Therapeutics Appoints Nicholas Maestas as Chief Financial Officer
globenewswire.com
RANI
Form 8-K
sec.gov
RANI
Form 8-K
sec.gov
RANI
Rani Therapeutics Holdings, Inc. Announces Pricing of $20.0 Million Registered Direct Offering of Class A Common Stock Priced At-The-Market Under Nasdaq Rules
globenewswire.com
RANI
Form 8-K
sec.gov
RANI
Rani Therapeutics Reports First Quarter 2026 Financial Results; Provides Corporate Update; Announces CFO Transition
globenewswire.com
RANI
Rani Therapeutics to Participate in the H.C. Wainwright Annual BioConnect Investor Conference
globenewswire.com
RANI
Rani Therapeutics Appoints Dr. Sara Kenkare-Mitra as Strategic Advisor to Advance Platform and Clinical Strategy
globenewswire.com
RANI
Form 8-K
sec.gov
RANI